Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengqiu Luo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
RNA Biology|June 26, 2025
Biology and utilization of R2 retrotransposonsShengqiu Luo, Qicheng Chen, Yangcan Chen, et al.
STAR Protocols|January 7, 2025
Protocol for evaluating the activity of R2 retrotransposons in mammalian cellsYangcan Chen, Shengqiu Luo, Yanping Hu, et al.
Cell Discovery|October 11, 2022
Metagenomic discovery of novel CRISPR-Cas13 systemsYanping Hu, Yangcan Chen, Jing Xu, et al.
Innovation (Cambridge (Mass.))|June 13, 2022
Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editingYangcan Chen, Yanping Hu, Xinge Wang, et al.
Plos Pathogens|December 14, 2020
Host RAB11FIP5 protein inhibits the release of Kaposi's sarcoma-associated herpesvirus particles by promoting lysosomal degradation of ORF45Xiaoqin Wei, Jiazhen Dong, Chin-Chen Cheng, et al.
Science China. Life Sciences|December 21, 2022
Computer-aided engineering of CRISPR-Cas proteins for enhanced human genome editingYangcan Chen, Yanping Hu, Shengqiu Luo, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 5, 2025
Dual-target CRISPR-Cas12 diagnostics based on asymmetrically chemical-modified DNA probeXinge Wang, Yangcan Chen, Yanping Hu, et al.
Cell|July 9, 2024
All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposonsYangcan Chen, Shengqiu Luo, Yanping Hu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
RNA Biology|June 26, 2025
Biology and utilization of R2 retrotransposonsShengqiu Luo, Qicheng Chen, Yangcan Chen, et al.
STAR Protocols|January 7, 2025
Protocol for evaluating the activity of R2 retrotransposons in mammalian cellsYangcan Chen, Shengqiu Luo, Yanping Hu, et al.
Cell Discovery|October 11, 2022
Metagenomic discovery of novel CRISPR-Cas13 systemsYanping Hu, Yangcan Chen, Jing Xu, et al.
Innovation (Cambridge (Mass.))|June 13, 2022
Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editingYangcan Chen, Yanping Hu, Xinge Wang, et al.
Plos Pathogens|December 14, 2020
Host RAB11FIP5 protein inhibits the release of Kaposi's sarcoma-associated herpesvirus particles by promoting lysosomal degradation of ORF45Xiaoqin Wei, Jiazhen Dong, Chin-Chen Cheng, et al.
Science China. Life Sciences|December 21, 2022
Computer-aided engineering of CRISPR-Cas proteins for enhanced human genome editingYangcan Chen, Yanping Hu, Shengqiu Luo, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 5, 2025
Dual-target CRISPR-Cas12 diagnostics based on asymmetrically chemical-modified DNA probeXinge Wang, Yangcan Chen, Yanping Hu, et al.
Cell|July 9, 2024
All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposonsYangcan Chen, Shengqiu Luo, Yanping Hu, et al.
Pageof 1